Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Accounts Payables (2016 - 2025)

Veracyte's Accounts Payables history spans 14 years, with the latest figure at $4.6 million for Q4 2025.

  • For Q4 2025, Accounts Payables fell 46.8% year-over-year to $4.6 million; the TTM value through Dec 2025 reached $4.6 million, down 46.8%, while the annual FY2025 figure was $4.6 million, 46.8% down from the prior year.
  • Accounts Payables for Q4 2025 was $4.6 million at Veracyte, down from $5.5 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $15.7 million in Q1 2025 and bottomed at $4.6 million in Q4 2025.
  • The 5-year median for Accounts Payables is $11.4 million (2022), against an average of $10.9 million.
  • The largest annual shift saw Accounts Payables surged 479.76% in 2021 before it tumbled 46.8% in 2025.
  • A 5-year view of Accounts Payables shows it stood at $12.4 million in 2021, then fell by 3.63% to $11.9 million in 2022, then rose by 8.66% to $12.9 million in 2023, then crashed by 33.29% to $8.6 million in 2024, then crashed by 46.8% to $4.6 million in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Accounts Payables are $4.6 million (Q4 2025), $5.5 million (Q3 2025), and $11.4 million (Q2 2025).